Clinical Trials Logo

Recurrent Nasopharyngeal Carcinoma clinical trials

View clinical trials related to Recurrent Nasopharyngeal Carcinoma.

Filter by:
  • None
  • Page 1

NCT ID: NCT03210389 Not yet recruiting - Clinical trials for Recurrent Nasopharyngeal Carcinoma

A Clinical Trial of Chemotherapy With Lobaplatin and 5-FU in Recurrent Local or Distant Advanced NPC.

Start date: July 2017
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of chemotherapy with Lobaplatin and 5-FU, in Recurrent Local or Distant Advanced Nasopharyngeal Carcinoma.

NCT ID: NCT01392235 Recruiting - Clinical trials for Recurrent Nasopharyngeal Carcinoma

Famitinib in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma (NPC)

Start date: June 2011
Phase: Phase 2
Study type: Interventional

RATIONALE: Famitinib is a tyrosin-inhibitor agent targeting at c-Kit, VEGFR2, PDGFR, VEGFR3, Flt1 and Flt3. Phase I study has shown that the drug's toxicity is manageable. PURPOSE: This phase II trial is studying how well famitinib works in treating patients with recurrent and/or metastatic NPC.

NCT ID: NCT01370070 Completed - Clinical trials for Recurrent Nasopharyngeal Carcinoma

MK-2206 in Recurrent Nasopharyngeal Carcinoma

MC1079
Start date: July 2011
Phase: Phase 2
Study type: Interventional

To evaluate the activity and safety of MK-2206 in patients with recurrent or metastatic nasopharyngeal carcinoma (NPC)